Mounjaro April 13, 2023 Mounjaro is a drug that belongs to a class called a dual glucose-dependent insulinotropic polypeptide (GLP) and Glucagon-like peptide-1 (GLP-1) receptor agonist. Mounjaro is considered to be the first medication in the GIP/GLP-1 Read More
Compounding Pharmacies vs. Big Pharma: The Battle for Dominance in the Growing GLP-1 Market October 22, 2024